Your browser doesn't support javascript.
loading
Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis.
Zhong, Xinxin; Lin, Ao; Luo, Jian; Li, Yeqin; Chen, Jinlan; Ning, Chao; Cao, Fu.
Afiliación
  • Zhong X; Department of Pulmonary and Critical Care Medicine, Red Cross Hospital of Yulin City, Yulin, Guangxi 537000, China.
  • Lin A; Department of Cardiothoracic Surgery, Red Cross Hospital of Yulin City, Yulin, Guangxi 537000, China.
  • Luo J; Department of Pulmonary and Critical Care Medicine, Red Cross Hospital of Yulin City, Yulin, Guangxi 537000, China.
  • Li Y; Department of Pulmonary and Critical Care Medicine, Red Cross Hospital of Yulin City, Yulin, Guangxi 537000, China.
  • Chen J; Department of Pulmonary and Critical Care Medicine, Red Cross Hospital of Yulin City, Yulin, Guangxi 537000, China.
  • Ning C; Department of Pulmonary and Critical Care Medicine, Red Cross Hospital of Yulin City, Yulin, Guangxi 537000, China.
  • Cao F; Department of Pulmonary and Critical Care Medicine, Red Cross Hospital of Yulin City, Yulin, Guangxi 537000, China.
Postgrad Med J ; 100(1184): 366-372, 2024 May 18.
Article en En | MEDLINE | ID: mdl-38200633
ABSTRACT
Multidrug-resistant tuberculosis (MDR-TB) has become a critical challenge to public health, and the prevention and treatment of MDR-TB are of great significance in reducing the global burden of tuberculosis. How to improve the effectiveness and safety of chemotherapy for MDR-TB is a pressing issue that needs to be addressed in tuberculosis control efforts. This article provides a comprehensive review of the clinical application of new antituberculosis drugs in MDR-TB, aiming to provide a scientific basis for the prevention and treatment strategy of MDR-TB.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Antituberculosos Límite: Humans Idioma: En Revista: Postgrad Med J Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Antituberculosos Límite: Humans Idioma: En Revista: Postgrad Med J Año: 2024 Tipo del documento: Article País de afiliación: China